ClinicalTrials.govpublic full text
ELDORADO: Elranatamab Versus Daratumumab in Combination With RVd Lite for Newly Diagnosed Transplant Ineligible/Deferred Multiple Myeloma
multiple myeloma, newly diagnosed multiple myeloma, transplant ineligible, newly diagnosed multiple myeloma (ndmm), ndmm, eldorado, rvd lite, transplant ineligible/deferred, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 979038
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.